Global Afinitor Market Growth 2022-2028
- LP 4871322
- 73 Pages
- February 2022
- Pharmaceuticals
The United States Afinitor market is expected at value of US$ million in 2021 and grow at approximately % CAGR during review period. China constitutes a % market for the global Afinitor market, reaching US$ million by the year 2028. As for the Europe Afinitor landscape, Germany is projected to reach US$ million by 2028 trailing a CAGR of % over the forecast period. In APAC, the growth rates of other notable markets (Japan and South Korea) are projected to be at % and % respectively for the next 5-year period.
Global main Afinitor players cover Novartis, , , and , etc. In terms of revenue, the global largest two companies occupy a share nearly % in 2021.
This report presents a comprehensive overview, market shares, and growth opportunities of Afinitor market by product type, application, key manufacturers and key regions and countries.
Segmentation by type: breakdown data from 2017 to 2022, in Section 2.3; and forecast to 2028 in section 12.6
2.5mg
5mg
7mg
10mg
Segmentation by application: breakdown data from 2017 to 2022, in Section 2.4; and forecast to 2028 in section 12.7.
Hospital
Drugs Store
Other
This report also splits the market by region: Breakdown data in Chapter 4, 5, 6, 7 and 8.
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries
The report also presents the market competition landscape and a corresponding detailed analysis of the prominent manufacturers in this market, include
Novartis
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
2 Executive Summary
2.1 World Market Overview
2.1.1 Global Afinitor Annual Sales 2017-2028
2.1.2 World Current & Future Analysis for Afinitor by Geographic Region, 2017, 2022 & 2028
2.1.3 World Current & Future Analysis for Afinitor by Country/Region, 2017, 2022 & 2028
2.2 Afinitor Segment by Type
2.2.1 2.5mg
2.2.2 5mg
2.2.3 7mg
2.2.4 10mg
2.3 Afinitor Sales by Type
2.3.1 Global Afinitor Sales Market Share by Type (2017-2022)
2.3.2 Global Afinitor Revenue and Market Share by Type (2017-2022)
2.3.3 Global Afinitor Sale Price by Type (2017-2022)
2.4 Afinitor Segment by Application
2.4.1 Hospital
2.4.2 Drugs Store
2.4.3 Other
2.5 Afinitor Sales by Application
2.5.1 Global Afinitor Sale Market Share by Application (2017-2022)
2.5.2 Global Afinitor Revenue and Market Share by Application (2017-2022)
2.5.3 Global Afinitor Sale Price by Application (2017-2022)
3 Global Afinitor by Company
3.1 Global Afinitor Breakdown Data by Company
3.1.1 Global Afinitor Annual Sales by Company (2020-2022)
3.1.2 Global Afinitor Sales Market Share by Company (2020-2022)
3.2 Global Afinitor Annual Revenue by Company (2020-2022)
3.2.1 Global Afinitor Revenue by Company (2020-2022)
3.2.2 Global Afinitor Revenue Market Share by Company (2020-2022)
3.3 Global Afinitor Sale Price by Company
3.4 Key Manufacturers Afinitor Producing Area Distribution, Sales Area, Product Type
3.4.1 Key Manufacturers Afinitor Product Location Distribution
3.4.2 Players Afinitor Products Offered
3.5 Market Concentration Rate Analysis
3.5.1 Competition Landscape Analysis
3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2020-2022)
3.6 New Products and Potential Entrants
3.7 Mergers & Acquisitions, Expansion
4 World Historic Review for Afinitor by Geographic Region
4.1 World Historic Afinitor Market Size by Geographic Region (2017-2022)
4.1.1 Global Afinitor Annual Sales by Geographic Region (2017-2022)
4.1.2 Global Afinitor Annual Revenue by Geographic Region
4.2 World Historic Afinitor Market Size by Country/Region (2017-2022)
4.2.1 Global Afinitor Annual Sales by Country/Region (2017-2022)
4.2.2 Global Afinitor Annual Revenue by Country/Region
4.3 Americas Afinitor Sales Growth
4.4 APAC Afinitor Sales Growth
4.5 Europe Afinitor Sales Growth
4.6 Middle East & Africa Afinitor Sales Growth
5 Americas
5.1 Americas Afinitor Sales by Country
5.1.1 Americas Afinitor Sales by Country (2017-2022)
5.1.2 Americas Afinitor Revenue by Country (2017-2022)
5.2 Americas Afinitor Sales by Type
5.3 Americas Afinitor Sales by Application
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Afinitor Sales by Region
6.1.1 APAC Afinitor Sales by Region (2017-2022)
6.1.2 APAC Afinitor Revenue by Region (2017-2022)
6.2 APAC Afinitor Sales by Type
6.3 APAC Afinitor Sales by Application
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 China Taiwan
7 Europe
7.1 Europe Afinitor by Country
7.1.1 Europe Afinitor Sales by Country (2017-2022)
7.1.2 Europe Afinitor Revenue by Country (2017-2022)
7.2 Europe Afinitor Sales by Type
7.3 Europe Afinitor Sales by Application
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 Middle East & Africa
8.1 Middle East & Africa Afinitor by Country
8.1.1 Middle East & Africa Afinitor Sales by Country (2017-2022)
8.1.2 Middle East & Africa Afinitor Revenue by Country (2017-2022)
8.2 Middle East & Africa Afinitor Sales by Type
8.3 Middle East & Africa Afinitor Sales by Application
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 Market Drivers, Challenges and Trends
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 Manufacturing Cost Structure Analysis
10.1 Raw Material and Suppliers
10.2 Manufacturing Cost Structure Analysis of Afinitor
10.3 Manufacturing Process Analysis of Afinitor
10.4 Industry Chain Structure of Afinitor
11 Marketing, Distributors and Customer
11.1 Sales Channel
11.1.1 Direct Channels
11.1.2 Indirect Channels
11.2 Afinitor Distributors
11.3 Afinitor Customer
12 World Forecast Review for Afinitor by Geographic Region
12.1 Global Afinitor Market Size Forecast by Region
12.1.1 Global Afinitor Forecast by Region (2023-2028)
12.1.2 Global Afinitor Annual Revenue Forecast by Region (2023-2028)
12.2 Americas Forecast by Country
12.3 APAC Forecast by Region
12.4 Europe Forecast by Country
12.5 Middle East & Africa Forecast by Country
12.6 Global Afinitor Forecast by Type
12.7 Global Afinitor Forecast by Application
13 Key Players Analysis
13.1 Novartis
13.1.1 Novartis Company Information
13.1.2 Novartis Afinitor Product Offered
13.1.3 Novartis Afinitor Sales, Revenue, Price and Gross Margin (2020-2022)
13.1.4 Novartis Main Business Overview
13.1.5 Novartis Latest Developments
14 Research Findings and Conclusion
Table 1. Afinitor Annual Sales CAGR by Geographic Region (2017, 2022 & 2028) & ($ millions)
Table 2. Afinitor Annual Sales CAGR by Country/Region (2017, 2022 & 2028) & ($ millions)
Table 3. Major Players of 2.5mg
Table 4. Major Players of 5mg
Table 5. Major Players of 7mg
Table 6. Major Players of 10mg
Table 7. Global Afinitor Sales by Type (2017-2022) & (MT)
Table 8. Global Afinitor Sales Market Share by Type (2017-2022)
Table 9. Global Afinitor Revenue by Type (2017-2022) & ($ million)
Table 10. Global Afinitor Revenue Market Share by Type (2017-2022)
Table 11. Global Afinitor Sale Price by Type (2017-2022) & (USD/Kg)
Table 12. Global Afinitor Sales by Application (2017-2022) & (MT)
Table 13. Global Afinitor Sales Market Share by Application (2017-2022)
Table 14. Global Afinitor Revenue by Application (2017-2022)
Table 15. Global Afinitor Revenue Market Share by Application (2017-2022)
Table 16. Global Afinitor Sale Price by Application (2017-2022) & (USD/Kg)
Table 17. Global Afinitor Sales by Company (2020-2022) & (MT)
Table 18. Global Afinitor Sales Market Share by Company (2020-2022)
Table 19. Global Afinitor Revenue by Company (2020-2022) ($ Millions)
Table 20. Global Afinitor Revenue Market Share by Company (2020-2022)
Table 21. Global Afinitor Sale Price by Company (2020-2022) & (USD/Kg)
Table 22. Key Manufacturers Afinitor Producing Area Distribution and Sales Area
Table 23. Players Afinitor Products Offered
Table 24. Afinitor Concentration Ratio (CR3, CR5 and CR10) & (2020-2022)
Table 25. New Products and Potential Entrants
Table 26. Mergers & Acquisitions, Expansion
Table 27. Global Afinitor Sales by Geographic Region (2017-2022) & (MT)
Table 28. Global Afinitor Sales Market Share Geographic Region (2017-2022)
Table 29. Global Afinitor Revenue by Geographic Region (2017-2022) & ($ millions)
Table 30. Global Afinitor Revenue Market Share by Geographic Region (2017-2022)
Table 31. Global Afinitor Sales by Country/Region (2017-2022) & (MT)
Table 32. Global Afinitor Sales Market Share by Country/Region (2017-2022)
Table 33. Global Afinitor Revenue by Country/Region (2017-2022) & ($ millions)
Table 34. Global Afinitor Revenue Market Share by Country/Region (2017-2022)
Table 35. Americas Afinitor Sales by Country (2017-2022) & (MT)
Table 36. Americas Afinitor Sales Market Share by Country (2017-2022)
Table 37. Americas Afinitor Revenue by Country (2017-2022) & ($ Millions)
Table 38. Americas Afinitor Revenue Market Share by Country (2017-2022)
Table 39. Americas Afinitor Sales by Type (2017-2022) & (MT)
Table 40. Americas Afinitor Sales Market Share by Type (2017-2022)
Table 41. Americas Afinitor Sales by Application (2017-2022) & (MT)
Table 42. Americas Afinitor Sales Market Share by Application (2017-2022)
Table 43. APAC Afinitor Sales by Region (2017-2022) & (MT)
Table 44. APAC Afinitor Sales Market Share by Region (2017-2022)
Table 45. APAC Afinitor Revenue by Region (2017-2022) & ($ Millions)
Table 46. APAC Afinitor Revenue Market Share by Region (2017-2022)
Table 47. APAC Afinitor Sales by Type (2017-2022) & (MT)
Table 48. APAC Afinitor Sales Market Share by Type (2017-2022)
Table 49. APAC Afinitor Sales by Application (2017-2022) & (MT)
Table 50. APAC Afinitor Sales Market Share by Application (2017-2022)
Table 51. Europe Afinitor Sales by Country (2017-2022) & (MT)
Table 52. Europe Afinitor Sales Market Share by Country (2017-2022)
Table 53. Europe Afinitor Revenue by Country (2017-2022) & ($ Millions)
Table 54. Europe Afinitor Revenue Market Share by Country (2017-2022)
Table 55. Europe Afinitor Sales by Type (2017-2022) & (MT)
Table 56. Europe Afinitor Sales Market Share by Type (2017-2022)
Table 57. Europe Afinitor Sales by Application (2017-2022) & (MT)
Table 58. Europe Afinitor Sales Market Share by Application (2017-2022)
Table 59. Middle East & Africa Afinitor Sales by Country (2017-2022) & (MT)
Table 60. Middle East & Africa Afinitor Sales Market Share by Country (2017-2022)
Table 61. Middle East & Africa Afinitor Revenue by Country (2017-2022) & ($ Millions)
Table 62. Middle East & Africa Afinitor Revenue Market Share by Country (2017-2022)
Table 63. Middle East & Africa Afinitor Sales by Type (2017-2022) & (MT)
Table 64. Middle East & Africa Afinitor Sales Market Share by Type (2017-2022)
Table 65. Middle East & Africa Afinitor Sales by Application (2017-2022) & (MT)
Table 66. Middle East & Africa Afinitor Sales Market Share by Application (2017-2022)
Table 67. Key Market Drivers & Growth Opportunities of Afinitor
Table 68. Key Market Challenges & Risks of Afinitor
Table 69. Key Industry Trends of Afinitor
Table 70. Afinitor Raw Material
Table 71. Key Suppliers of Raw Materials
Table 72. Afinitor Distributors List
Table 73. Afinitor Customer List
Table 74. Global Afinitor Sales Forecast by Region (2023-2028) & (MT)
Table 75. Global Afinitor Sales Market Forecast by Region
Table 76. Global Afinitor Revenue Forecast by Region (2023-2028) & ($ millions)
Table 77. Global Afinitor Revenue Market Share Forecast by Region (2023-2028)
Table 78. Americas Afinitor Sales Forecast by Country (2023-2028) & (MT)
Table 79. Americas Afinitor Revenue Forecast by Country (2023-2028) & ($ millions)
Table 80. APAC Afinitor Sales Forecast by Region (2023-2028) & (MT)
Table 81. APAC Afinitor Revenue Forecast by Region (2023-2028) & ($ millions)
Table 82. Europe Afinitor Sales Forecast by Country (2023-2028) & (MT)
Table 83. Europe Afinitor Revenue Forecast by Country (2023-2028) & ($ millions)
Table 84. Middle East & Africa Afinitor Sales Forecast by Country (2023-2028) & (MT)
Table 85. Middle East & Africa Afinitor Revenue Forecast by Country (2023-2028) & ($ millions)
Table 86. Global Afinitor Sales Forecast by Type (2023-2028) & (MT)
Table 87. Global Afinitor Sales Market Share Forecast by Type (2023-2028)
Table 88. Global Afinitor Revenue Forecast by Type (2023-2028) & ($ Millions)
Table 89. Global Afinitor Revenue Market Share Forecast by Type (2023-2028)
Table 90. Global Afinitor Sales Forecast by Application (2023-2028) & (MT)
Table 91. Global Afinitor Sales Market Share Forecast by Application (2023-2028)
Table 92. Global Afinitor Revenue Forecast by Application (2023-2028) & ($ Millions)
Table 93. Global Afinitor Revenue Market Share Forecast by Application (2023-2028)
Table 94. Novartis Basic Information, Afinitor Manufacturing Base, Sales Area and Its Competitors
Table 95. Novartis Afinitor Product Offered
Table 96. Novartis Afinitor Sales (MT), Revenue ($ Million), Price (USD/Kg) and Gross Margin (2020-2022)
Table 97. Novartis Main Business
Table 98. Novartis Latest Developments
List of Figures
Figure 1. Picture of Afinitor
Figure 2. Afinitor Report Years Considered
Figure 3. Research Objectives
Figure 4. Research Methodology
Figure 5. Research Process and Data Source
Figure 6. Global Afinitor Sales Growth Rate 2017-2028 (MT)
Figure 7. Global Afinitor Revenue Growth Rate 2017-2028 ($ Millions)
Figure 8. Afinitor Sales by Region (2021 & 2028) & ($ millions)
Figure 9. Product Picture of 2.5mg
Figure 10. Product Picture of 5mg
Figure 11. Product Picture of 7mg
Figure 12. Product Picture of 10mg
Figure 13. Global Afinitor Sales Market Share by Type in 2021
Figure 14. Global Afinitor Revenue Market Share by Type (2017-2022)
Figure 15. Afinitor Consumed in Hospital
Figure 16. Global Afinitor Market: Hospital (2017-2022) & (MT)
Figure 17. Afinitor Consumed in Drugs Store
Figure 18. Global Afinitor Market: Drugs Store (2017-2022) & (MT)
Figure 19. Afinitor Consumed in Other
Figure 20. Global Afinitor Market: Other (2017-2022) & (MT)
Figure 21. Global Afinitor Sales Market Share by Application (2017-2022)
Figure 22. Global Afinitor Revenue Market Share by Application in 2021
Figure 23. Afinitor Revenue Market by Company in 2021 ($ Million)
Figure 24. Global Afinitor Revenue Market Share by Company in 2021
Figure 25. Global Afinitor Sales Market Share by Geographic Region (2017-2022)
Figure 26. Global Afinitor Revenue Market Share by Geographic Region in 2021
Figure 27. Global Afinitor Sales Market Share by Region (2017-2022)
Figure 28. Global Afinitor Revenue Market Share by Country/Region in 2021
Figure 29. Americas Afinitor Sales 2017-2022 (MT)
Figure 30. Americas Afinitor Revenue 2017-2022 ($ Millions)
Figure 31. APAC Afinitor Sales 2017-2022 (MT)
Figure 32. APAC Afinitor Revenue 2017-2022 ($ Millions)
Figure 33. Europe Afinitor Sales 2017-2022 (MT)
Figure 34. Europe Afinitor Revenue 2017-2022 ($ Millions)
Figure 35. Middle East & Africa Afinitor Sales 2017-2022 (MT)
Figure 36. Middle East & Africa Afinitor Revenue 2017-2022 ($ Millions)
Figure 37. Americas Afinitor Sales Market Share by Country in 2021
Figure 38. Americas Afinitor Revenue Market Share by Country in 2021
Figure 39. United States Afinitor Revenue Growth 2017-2022 ($ Millions)
Figure 40. Canada Afinitor Revenue Growth 2017-2022 ($ Millions)
Figure 41. Mexico Afinitor Revenue Growth 2017-2022 ($ Millions)
Figure 42. Brazil Afinitor Revenue Growth 2017-2022 ($ Millions)
Figure 43. APAC Afinitor Sales Market Share by Region in 2021
Figure 44. APAC Afinitor Revenue Market Share by Regions in 2021
Figure 45. China Afinitor Revenue Growth 2017-2022 ($ Millions)
Figure 46. Japan Afinitor Revenue Growth 2017-2022 ($ Millions)
Figure 47. South Korea Afinitor Revenue Growth 2017-2022 ($ Millions)
Figure 48. Southeast Asia Afinitor Revenue Growth 2017-2022 ($ Millions)
Figure 49. India Afinitor Revenue Growth 2017-2022 ($ Millions)
Figure 50. Australia Afinitor Revenue Growth 2017-2022 ($ Millions)
Figure 51. Europe Afinitor Sales Market Share by Country in 2021
Figure 52. Europe Afinitor Revenue Market Share by Country in 2021
Figure 53. Germany Afinitor Revenue Growth 2017-2022 ($ Millions)
Figure 54. France Afinitor Revenue Growth 2017-2022 ($ Millions)
Figure 55. UK Afinitor Revenue Growth 2017-2022 ($ Millions)
Figure 56. Italy Afinitor Revenue Growth 2017-2022 ($ Millions)
Figure 57. Russia Afinitor Revenue Growth 2017-2022 ($ Millions)
Figure 58. Middle East & Africa Afinitor Sales Market Share by Country in 2021
Figure 59. Middle East & Africa Afinitor Revenue Market Share by Country in 2021
Figure 60. Egypt Afinitor Revenue Growth 2017-2022 ($ Millions)
Figure 61. South Africa Afinitor Revenue Growth 2017-2022 ($ Millions)
Figure 62. Israel Afinitor Revenue Growth 2017-2022 ($ Millions)
Figure 63. Turkey Afinitor Revenue Growth 2017-2022 ($ Millions)
Figure 64. GCC Country Afinitor Revenue Growth 2017-2022 ($ Millions)
Figure 65. Manufacturing Cost Structure Analysis of Afinitor in 2021
Figure 66. Manufacturing Process Analysis of Afinitor
Figure 67. Industry Chain Structure of Afinitor
Figure 68. Channels of Distribution
Figure 69. Distributors Profiles
Similar Reports
The United States pneumococcal & meningococcal vaccines market is set to surpass US$ 7.5 Million by the year end of 2025. “United States Pneumococcal & Meningococcal Vaccines Market by Company Profile, Deals Type, Brand Analysis, Share, Key Trends & Opportunities to 2025” presents an in–depth assessment of the United States pneumococcal & meningococcal vaccines market dynamics, opportunitie...
- Publish Date: June 24, 2019
- $1050
The global human immunodeficiency virus (HIV) drugs market size is expected to surpass US$ 30 billion by 2025. “Global Human Immunodeficiency Virus (HIV) Drugs Market 2019 – 2025: Top 22 Drugs Analysis, Key Trends, Players and Forecasts” presents an in-depth assessment of the global human immunodeficiency virus (HIV) drugs market dynamics, opportunities, future roadmap, competitive landscap...
- Publish Date: February 18, 2019
- $1290
The global 50 blockbuster drugs market size is estimated to reach a value of US$ 292 billion by 2025. ‘’Global Blockbuster Drugs Market 2015 - 2025: Top 50 Drugs Analysis, Deal Trends, Players and Forecasts” presents an in-depth assessment of the global blockbuster drugs market dynamics, opportunities, future roadmap, competitive landscape and discusses major trends. The report offers the m...
- Publish Date: December 11, 2018
- $1390
